MTCO1P7

Across TCGA pan-cancer cohorts, MTCO1P7 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MTCO1P7 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MTCO1P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTCO1P7 expression acts as an unfavorable survival marker, although some lineages such as ACC and READ show a favorable association.

UCEC, CESC, and ACC are the cancer types where MTCO1P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Quartile	II,III,IV	0.764	0.877	.005	92	view →
CESC	OS	Quartile	III,IV	0.358	0.713	.001	74	view →
ACC	DFS	Median	All	0.756	0.345	<.001	47	view →
READ	DFS	Tertile	II,III,IV	0.959	0.698	.016	32	view →
KICH	OS	Tertile	II,III,IV	0.201	1.000	<.001	30	view →
BLCA	DFS	Tertile	IV	0.309	0.526	.003	27	view →
ESCA	DFS	Quartile	All	0.179	1.000	.001	27	view →
UVM	DFS	Tertile	II,III,IV	0.360	0.656	.014	18	view →
MESO	DFS	Tertile	IV	0.770	0.252	.026	15	view →
SKCM	OS	Tertile	II,III,IV	0.903	0.812	.008	14	view →
LUSC	DFS	Quartile	III,IV	0.595	0.293	.019	12	view →
STAD	DFS	Quartile	II,III,IV	0.326	0.601	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MTCO1P7–UCEC (OS)

Open the UCEC breakdown →